A bone graft repairs and rebuilds diseased bone and transplants bone tissues of the hips, knees, spine, and various other bones in the body. Moreover, it repairs bone loss caused by fractures and cancers. The body accepts the newly implanted graft and provides a framework for growth of new living bone. Bone grafts can be obtained either from the patient’s own body, a donor or can be entirely man-made from natural or synthetic materials. Autografts and allograft are the most common types of bone grafts. In allograft, bone is obtained from a deceased donor or a cadaver that is sterilized and stored in the tissue or bone banks. In autografts, bone is obtained from the patient’s own body parts such as ribs, pelvis, wrist, and hips. Furthermore, bone graft substitutes made up of materials such as ceramics and polymers are gaining preference. This is owing to osteoconductive and osteogenerative properties and easy availability of these grafts.

Market Dynamics

Latin America bone graft and substitutes market is expected to witness significant growth over the forecast period, owing to increasing adoption of new technologies by manufacturers to develop novel bone graft substitutes. For instance, in March 2015, Osiris Therapeutics, Inc., a company based in Columbia, Maryland, introduced BIO4. BIO4 is a viable bone matrix containing endogenous bone forming cells including mesenchymal stem cells, osteoprogenitor cells, osteoblasts, osteoinductive, and angiogenic growth factors. BIO4 has all four characteristics involved in bone repair and regeneration including osteoconductive, osteoinductive, osteogenic, and angiogenic characteristics. It is a safe alternative to bone autograft that minimizes the potential for harvest site co-morbidities.

Furthermore, demand for implants possessing enhanced porosity, mechanical strength as well as biocompatibility is increasing, which in turn is expected to drive the market growth. One such parameter can be fulfilled through the use of bioactive glass in the implants that helps to improve mechanical integrity of graft substitutes. Thus, market players focusing on biocompatibility of implants providing sufficient mechanical integrity, have potential opportunity to capitalize upon this area and generate significant revenue over the forecast period.

Key features of the study

• This report provides in-depth analysis of Latin America bone graft and substitutes market size (USD Mn), and cumulative annual growth rate (CAGR (%)) for the forecast period: 2018 – 2026, considering 2018, as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in Latin America bone graft and substitutes market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
• Key players covered as a part of this study include, RTI Surgical, Inc., NuVasive, Inc., Exactech, Inc., Medtronic Plc., LifeNet Health, Zimmer Biomet Holdings, Inc., Stryker Corporation, Johnson & Johnson, Orthofix International N.V., Ace Surgical Supply Co., Inc., and  Novabone Product, LLC
• Insights from this report would allow marketers and management authorities of companies to make informed decision with respect to their future product launch, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
• Latin America bone graft and substitutes market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors and suppliers for anesthesia device market, research and consulting firms, new entrants, and financial analysts

Market Segmentation

• Product Type Insights (Revenue, USD Mn, 2026 - 2033)
  • Bone Graft
    • Allografts
    • Xenografts
  • Bone Graft Substitutes
    • Ceramics
    • Composites
    • Polymers
    • Bone Morphogenetics Proteins
    • Others
• Application Insights (Revenue, USD Mn, 2026 - 2033)
  • Spinal Fusion
  • Dental Bone Grafts
  • Craniomaxillofacial
  • Joint Reconstruction
  • Trauma
• Country Insights (Revenue, USD Mn, 2026 - 2033)
  • Colombia
  • Peru
  • Chile
  • Rest of Latin America
• Key Players Insights
  • RTI Surgical, Inc.
  • NuVasive, Inc.
  • xactech, Inc.
  • Medtronic Plc.
  • LifeNet Health
  • Zimmer Biomet Holdings, Inc.
  • Stryker Corporation
  • Johnson & Johnson
  • Orthofix International N.V.
  • Ace Surgical Supply Co., Inc.
  • Novabone Product, LLC